Park J Y, Gwak G Y, Kim J M, Oh H J, Yi N J, Suh K S, Kim D K, Lim C S, Kim Y S, Lee J P
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Transplant Proc. 2015 Apr;47(3):709-17. doi: 10.1016/j.transproceed.2014.10.057.
Liver transplantation (LT) is the treatment of choice for hepatorenal syndrome (HRS). Recently, acute kidney injury (AKI) due to acute hepatitis A (HA) is increasing, but the outcome of LT is not well established. We investigated the outcomes of LT in patients with AKI due to acute HA compared with those of patients with HRS due to other causes.
We investigated the outcomes of LT in 20 patients with AKI associated with acute HA (HAV group) compared with 76 patients with hepatorenal syndrome (HRS) due to other causes (HRS group) at 3 Korea centers.
Preoperative mean prothrombin time and serum creatinine level were higher in the HAV group than in the HRS group. But mean total bilirubin level was lower in the HAV group. There was no difference in Model for End-Stage Liver Disease scores. Post-transplantation patient and graft survival rates were similar between the 2 groups. More patients in the HAV group needed post-transplantation hemodialysis than in the HRS group (65.0% vs 38.2%; P = .043). However, post-transplantation estimated glomerular filtration rate was significantly higher in the HAV group after post-transplantation month 2 (P < .05).
Peri-transplantation kidney function of the HAV group was poorer than that of HRS group. However, post-transplantation long-term renal outcome could be better in the HAV group.
肝移植(LT)是肝肾综合征(HRS)的首选治疗方法。近年来,急性甲型肝炎(HA)所致的急性肾损伤(AKI)呈上升趋势,但肝移植的结局尚未明确。我们比较了急性HA所致AKI患者与其他原因所致HRS患者肝移植的结局。
我们在韩国的3个中心调查了20例急性HA相关AKI患者(HAV组)与76例其他原因所致肝肾综合征(HRS组)患者的肝移植结局。
HAV组术前平均凝血酶原时间和血清肌酐水平高于HRS组。但HAV组平均总胆红素水平较低。终末期肝病模型评分无差异。两组移植后患者和移植物存活率相似。HAV组比HRS组更多患者需要移植后血液透析(65.0%对38.2%;P = 0.043)。然而,移植后第2个月后HAV组的移植后估计肾小球滤过率显著更高(P < 0.05)。
HAV组围移植期肾功能比HRS组差。然而,HAV组移植后长期肾脏结局可能更好。